As the world races to find a vaccine for COVID-19, our colleague Dr Cem Gun, an Emergency Medicine Physician at Acıbadem University Atakent Hospital, has bravely volunteered for the country’s first clinical trial. On 9 October, he was administered the first dose of a COVID-19 vaccine developed in China and approved for trial by the Health Institutes of Turkey, at a high-key milestone event.
On why he volunteered for this trial, Dr Cem Gun said, “As a healthcare worker, I fall into the high-risk group for COVID-19 infection. I decided to be vaccinated not only to protect myself but also my patients and loved ones. I made this decision with peace of mind as it is a controlled trial; it is currently in Phase 3, making it a tested and safe vaccine.”
The vaccine will be administered in two doses, and volunteers will be monitored on its effectiveness over a year.
The World Bank has approved US$12 billion in financing to help developing countries buy and distribute COVID-19 vaccines, tests and treatments, aiming to support the vaccination of up to 1 billion people.
Related Stories
.webp?sfvrsn=39fb95d5_1)
A Monumental Message of Hope: Gleneagles Hospital Mumbai Sets Guinness World Record for Organ Donation Awareness
-(1).png?sfvrsn=7f37c489_1)
Gleneagles Hospital Hong Kong Advances Cross-Border Healthcare Innovation
Healthcare leaders gathered at BIOHK2026 to exchange ideas, share insights and explore new opportunities to advance healthcare innovation across borders.
d3f844a27f764fc6a1d9162e340ea5d7.jpg?sfvrsn=ba8e0bb3_1)
Sea Fiesta Connects Colleagues, Families and Friends
A shared evening of connection, appreciation and celebration, bringing together colleagues, families and friends behind the moments that matter most.
Smarter Hospital Operations: How IHH Singapore Saves 31,000 Hours Annually Through Innovation
Pantai Hospital Melaka Launches Malaysia's First Smart Fridge Hub for Oncology Medicines
Pantai Hospital Melaka, part of IHH Healthcare, has become the first hospital in Malaysia to launch a Smart Fridge micro-inventory hub for selected oncology medicines, marking a significant step forward in improving access to cancer treatment.
